Clinical Trials
All Clinical Trials - Page 58 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01272219Phase 3Completed
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
Liraglutide
- NCT01382719Phase 2Completed
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
PT-141
- NCT01430195Phase 1Completed
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
Afamelanotide
- NCT01402336Phase 3Completed
GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
Gonadorelin
- NCT01373450Phase 1Completed
Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
Liraglutide
- NCT01373216Phase 3Completed
Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
Exenatide
- NCT01313273Phase 3Terminated
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
Gonadorelin
- NCT01368913N/ACompleted
MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
Desmopressin
- NCT02084797N/ACompleted
V2 Receptor Effects on Fluid Regulation and Performance
Desmopressin
- NCT01427387Phase 1Completed
A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects
Linaclotide
- NCT01336023Phase 3Completed
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01410799Phase 2Terminated
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Sermorelin
- NCT02366208Phase 2Completed
Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B
Thymosin-Alpha-1
- NCT01257802Phase 3Terminated
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Gonadorelin
- NCT01353846Phase 4Unknown
Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients
Gonadorelin
- NCT01399645Phase 2Completed
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
Liraglutide
- NCT01360424Phase 4Completed
Teriparatide Treatment in Patients With Inherited Osteoporosis
Teriparatide
- NCT01377246Phase 3Completed
Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Octreotide
- NCT01354405N/ACompleted
Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
Lanreotide
- NCT00898326N/ACompleted
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer
Gonadorelin
- NCT01280344Phase 2Completed
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Ipamorelin
- NCT01360840Phase 2Completed
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Gonadorelin
- NCT02292290Phase 4Completed
Trial for People With Established Type 2 Diabetes During Ramadan
Liraglutide
- NCT01343004Phase 3Completed
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
Teriparatide
- NCT01645475Phase 4Completed
Desmopressin Melt: Impact on Sleep and Daytime Functioning
Desmopressin
- NCT01296412Phase 3Completed
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
Liraglutide
- NCT01302327N/AWithdrawn
GLP Analogs for Diabetes in Wolfram Syndrome Patients
Exenatide
- NCT01393132Phase 2Completed
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
TB-500
- NCT01359488Phase 1Completed
VRS-317 in Adult Subjects With Growth Hormone Deficiency
Sermorelin
- NCT01319240Phase 1Completed
Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
Liraglutide
- NCT01575301N/ACompleted
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Liraglutide
- NCT01324388Phase 1Completed
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
Dulaglutide
- NCT01342042Phase 2Unknown
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Exenatide
- NCT01315795Phase 2/Phase 3Completed
Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
Lanreotide
- NCT01817569N/ACompleted
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
Exenatide
- NCT01416649N/ACompleted
Impact of Exenatide on Sleep Duration
Exenatide
- NCT01240941Phase 2Withdrawn
Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
Gonadorelin
- NCT01294371N/ACompleted
Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)
Gonadorelin
- NCT01288326N/ACompleted
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01301092Phase 1Completed
A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.
Dulaglutide
- NCT01300260Phase 1Completed
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
Dulaglutide
- NCT01381926Phase 4Terminated
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
Exenatide
- NCT01297062Phase 1Completed
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
Exenatide
- NCT01434862N/ATerminated
Pramlintide Combined With Model Predictive Control Algorithm
Pramlintide
- NCT01321723Phase 2Completed
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women
Teriparatide
- NCT01279187Phase 2Terminated
The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone
Teriparatide
- NCT01295060Phase 3Terminated
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Octreotide
- NCT01262456Phase 3Completed
Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
Desmopressin
- NCT02661789N/ACompleted
Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression
Gonadorelin
- NCT02342197Phase 3Completed
Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation
Gonadorelin